Serum Adiponectin Confers Little Protection Against Diabetes and Hypertension in Turkish Men (original) (raw)
Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men
Rei Otsuka
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
View PDFchevron_right
Predictive value of high-molecular weight adiponectin in subjects with a higher risk of the development of metabolic syndrome: From a population based 5-year follow-up data
Norihiko Kotooka
International Journal of Cardiology, 2013
View PDFchevron_right
Association of Adiponectin with Components of Metabolic Syndrome in Western U
Prema Adhikari
2019
View PDFchevron_right
Further inflammatory information on metabolic syndrome by adiponectin evaluation
Rei Otsuka
International Journal of Cardiology, 2008
View PDFchevron_right
Adiponectin circulating levels and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA Study
christina chrysohoou
Endocrine, 2017
View PDFchevron_right
Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study
Smaragdi Antonopoulou
Lipids in Health and Disease
View PDFchevron_right
Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome
Panca Dewi Purwati
Diabetes & Metabolism, 2017
View PDFchevron_right
High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, "adiponectin paradox": The Korean Longitudinal Study on Health and Aging (KLoSHA)
Soo Lim
International journal of cardiology, 2015
View PDFchevron_right
A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study
Costan Magnussen, Markus Juonala, Mervi Oikonen, Terho Lehtimäki
Atherosclerosis, 2011
View PDFchevron_right
Adiponectin: An Emerging Cardiovascular Risk Factor. The REFERENCE Study
Vivencio Barrios
Revista Española de Cardiología (English Edition), 2008
View PDFchevron_right
Adiponectin: a link between excess adiposity and associated comorbidities?
O. Ukkola
Journal of Molecular Medicine-jmm, 2002
View PDFchevron_right
Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome
Song Vogue Ahn
Diabetes Care, 2012
View PDFchevron_right
Adiponectin and Risk of Coronary Heart Disease in Older Men and Women
Joshua Barzilay
The Journal of Clinical Endocrinology and Metabolism, 2008
View PDFchevron_right
Serum adiponectin levels in patients with coronary artery disease
Prof. Iram Fayyaz
Journal of Ayub Medical College, Abbottabad : JAMC
View PDFchevron_right
Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity
Brendan McQuillan
International journal of obesity (2005), 2008
View PDFchevron_right
Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance
Peter George
Diabetes, Obesity and Metabolism, 2003
View PDFchevron_right
Major components of metabolic syndrome and adiponectin levels: a cross-sectional study
Sheila Garcia
Diabetology & Metabolic Syndrome, 2014
View PDFchevron_right
Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study
Stefania Lamon-fava
Atherosclerosis, 2011
View PDFchevron_right
Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study
Susanne May
American Journal of Epidemiology, 2006
View PDFchevron_right
Implications of plasma concentrations of adiponectin in patients with coronary artery disease
Shoichi Ehara
Heart, 2004
View PDFchevron_right
Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) study
Gunter Almer
Clinica Chimica Acta, 2006
View PDFchevron_right
The relationship between serum adiponectin levels with the presence and severity of coronary artery disease
Mesbah Shams
Archives of Iranian medicine, 2012
View PDFchevron_right
[Adiponectin and atherosclerosis]
Tomas Roubicek
Vnitr̆ní lékar̆ství, 2007
View PDFchevron_right
Adiponectin circulating levels: A new emerging biomarker of cardiovascular risk
Silvia Ry
Pharmacological Research, 2007
View PDFchevron_right
Study of plasma adiponectin level in patients with metabolic syndrome
Amal Medicine, nagwa abd el-ghaffar
International Journal of Research in Medical Sciences, 2015
View PDFchevron_right
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study
R. Schnabel
European Heart Journal, 2008
View PDFchevron_right
Adiponectin: a key adipocytokine in metabolic syndrome
Yuji Matsuzawa
Clinical …, 2006
View PDFchevron_right